Overall verdict
Neutral
6.4/10
1-year performance
+101.52%
Score breakdown
Up 101.5% over 1 year, 62% of the 52-week range.
Strongest: Growth 7.6/10. Weakest: Financial strength 2.7/10.
17 analysts, target +0.4% vs the price.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
Sector
Health Care
Industry
Health Care Providers and Services
Primary listing
Nasdaq
United States
CEO
Jon Rousseau
Founded
1974
Employees
23 500
Revenue / employee
549 386 USD
Next earnings
October 29, 2026 (estimated)
Institutional holders
- Kohlberg Kravis Roberts & Co. L.P.13.57%
- BlackRock, Inc.12.40%
- FMR LLC6.82%
- Invesco Ltd.6.05%
- VANGUARD PORTFOLIO MANAGEMENT LLC5.03%
- PRICE T ROWE ASSOCIATES INC /MD/5.01%
- VANGUARD CAPITAL MANAGEMENT LLC3.70%
- STATE STREET CORP3.17%
- T. Rowe Price Investment Management, Inc.3.06%
- Other institutions47.43%
434 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
73.75 USD
52-week low
26.28 USD
1-year performance
101.52%
Rising
Year-to-date performance
48.67%
Rising
Drawdown
-24.32%
Marked drawdown
Position in the 52-week range
62% of range
Range: 70.00 USD - 70.11 USD (2 methods agree)
The price implies growth of 9.24% per year; the company grows at -10.00%.
Gross margin 12.4%, net margin 1.7%, ROIC 5.7%, ROE 13.1%.
Net margin
1.73%
Low
Sector 3.25%|S&P 12.97%
Gross margin
12.38%
Low
Return on equity (ROE)
13.11%
Exceptional
Sector 6.71%|S&P 16.52%
Return on invested capital (ROIC)
5.71%
High
Free cash flow margin (FCF)
2.78%
Low
Profit-to-cash conversion (FCF conversion)
1.61x
Fair
Margin stability
1.1 pts
Very steady
Revenue to net income
Growth
7.6/10Revenue up 23.0% over 1 year, 18.3% a year over 5, EPS -20.8% a year over 5.
Revenue (trailing 12 months)
14.4Md USD
Revenue growth (1y)
23.05%
Hyper-growth
Revenue growth (3y)
67.22%
Strong
EPS growth (1y)
201.76%
Hyper-growth
EPS CAGR (5y)
-20.78%
Declining
EPS revisions (3 months)
7.70%
Sharply revised up
Valuation
4.1/10P/E 41.7x, forward P/E 34.4x, EV/EBITDA 20.8x, PEG 0.12.
P/E (TTM)
41.7x
Expensive
Sector 27.2x|S&P 23.0x
Forward P/E
34.4x
Expensive
EV / EBITDA
20.8x
Expensive
Sector 12.6x|S&P 14.5x
PEG
0.12
Growth unpriced
Sector 0.75|S&P 0.86
Fair value (reverse DCF)
70.05 USD
Undervalued
Market cap
11.0Md USD
Financial strength
2.7/10Cash covers 23.1% of the debt, net debt/EBITDA 4.6x.
Net debt / EBITDA
4.6x
Stretched
Gearing (net debt / equity)
89.27%
Tight
Cash
550M USD
Cash / market cap
4.99%
Tight
Cash / total debt
23.05%
Tight
Interest coverage
2.9x
Tight
Net debt
1.8Md USD
Equity
2.1Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 56.02 USD
- MM2058.84
- MM5062.07
- MM20051.64
- RSI 1440.1
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+5.34%
200-day average slope, 3 months
+24.76%
50-day average slope, 1 month
-6.07%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
2.33 % per day
Volatility change
-18.86%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 1.62 (7) | 1.82 (17) | 15 364 (17) | 837 (17) | 365 (8) |
| 2027 | 2.00 (7) | 2.28 (17) | 17 424 (18) | 977 (17) | 440 (7) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 16, 2026.
Same sub-industry: 77 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HNGE | 7.2 | 6.6 | 7.4Md USD | 71.1x | 14.8 % | 53.0 % | 29.3 % | -3.8x | 3.8 % | 55.7 % | ||
| 2 | CI | 6.9 | 7.0 | 70.9Md USD | 11.1x | 2.3 % | 6.5 % | 9.3 % | 1.8x | 12.9 % | -8.0 % | ||
| 3 | LH | 6.7 | 5.9 | 24.7Md USD | 25.1x | 7.0 % | 5.8 % | 6.8 % | 2.4x | 4.7 % | 10.4 % | ||
| 4 | CVS | 6.6 | 5.9 | 110Md USD | 22.7x | 1.2 % | 7.2 % | 3.2 % | 4.1x | 10.7 % | 10.9 % | ||
| 5 | DVA | 6.6 | 6.5 | 11.7Md USD | 15.4x | 5.9 % | 5.2 % | 6.9 % | 4.5x | 13.8 % | 32.3 % | ||
| 6 | BTSG | 6.4 | 5.2 | 11.0Md USD | 41.7x | 1.7 % | 23.0 % | 5.7 % | 4.6x | 3.6 % | 101.5 % | ||
| 7 | DGX | 6.4 | 5.7 | 25.7Md USD | 24.7x | 9.2 % | 10.2 % | 7.9 % | 2.8x | 5.2 % | 26.9 % | ||
| 8 | FME | 5.3 | 6.7 | 12.0Md USD | 11.8x | 4.8 % | 1.4 % | 4.3 % | 2.7x | 17.0 % | -10.0 % | ||
| 9 | GH | 4.7 | 2.6 | 23.7Md USD | Not meaningful (loss) | -38.3 % | 44.3 % | -37.0 % | -1.5x | -1.0 % | 189.0 % |
